Iqra Mumal, MSc,  —

Iqra holds a MSc in Cellular and Molecular Medicine from the University of Ottawa in Ottawa, Canada. She also holds a BSc in Life Sciences from Queen’s University in Kingston, Canada. Currently, she is completing a PhD in Laboratory Medicine and Pathobiology from the University of Toronto in Toronto, Canada. Her research has ranged from across various disease areas including Alzheimer’s disease, myelodysplastic syndrome, bleeding disorders and rare pediatric brain tumors.

Articles by Iqra Mumal

Study Updates Prevalence of Cushing’s Syndrome Diagnoses in Sweden

In the modern era, three new cases of Cushing’s syndrome are being diagnosed annually per one million inhabitants, according to results from a study conducted in a region of Sweden. Also, more patients with ectopic Cushing’s syndrome are being diagnosed compared to prior reports, which researchers attribute to an increased awareness…

Hormonal Stimulation Improves Tumor Detection in Cushing’s, Study Finds

Giving corticotropin-releasing hormone (CRH) to Cushing’s disease patients helps improve the detection of pituitary tumors on positron emission tomography (PET) scans, increasing the chances of a more successful surgery, a study shows. The study, “CRH stimulation improves 18F-FDG-PET detection of pituitary adenomas in Cushing’s disease,” was published in the journal…

Surgical Removal of Pituitary Adenomas Through the Nose Remains an Effective Treatment for Pediatric Patients, Study Finds

Removal of pituitary adenomas by inserting surgical instruments through the nose (transsphenoidal resection) remains the best treatment option for pediatric patients, despite its inherent technical difficulties, a new study shows. The study, “Transsphenoidal surgery for pituitary adenomas in pediatric patients: a multicentric retrospective study,” was…